Rituximab for Rheumatoid Arthritis Marc D. CohenEdward Keystone Review Open access 19 August 2015 Pages: 99 - 111
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party Jason MadanTony AdesAllan Wailoo Original Research Open access 25 November 2015 Pages: 113 - 125
Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs Nicole M. Engel-NitzSarika OgaleMahesh Kulakodlu Original Research Open access 25 August 2015 Pages: 127 - 139
Influence of Continuing Medical Education on Rheumatologists’ Performance on National Quality Measures for Rheumatoid Arthritis Tamar SapirErica RusieKathleen Moreo Original Research Open access 01 October 2015 Pages: 141 - 151
Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry Dimitrios A. PappasJeffrey D. KentRobert J. Holt Original Research Open access 29 September 2015 Pages: 153 - 164
Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study Klara MorsleyThomas KilnerAlan Steuer Original Research Open access 25 November 2015 Pages: 165 - 172
Predictors of Atherosclerosis in Ankylosing Spondylitis Inderjeet VermaPawan KrishanAshit Syngle Original Research Open access 30 August 2015 Pages: 173 - 182
Pharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC–MS/MS Hong-wei FanZhi-xiang MaYing-bin Li Original Research Open access 10 July 2015 Pages: 183 - 195